Biomarin Pharmaceutical
Price & Volume
Stats
See more52W Range | $61.15-$99.25 |
Market Cap | $12.5B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $2.7B |
Revenue Growth (YoY) | 28.3% |
Gross Profit (12 Mos) | $1.6B |
Diluted EPS | $1.66 |
News
See moreYahoo Finance • 5 months ago
U.S. Food and Drug Administration Approves BioMarin's BRINEURA® (cerliponase alfa) for Children Under 3 Years with CLN2 Disease
Yahoo Finance • 8 months ago
4 Dominant Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
Yahoo Finance • 9 months ago
30 Biggest Biotechnology Companies in the World
Yahoo Finance • 10 months ago
UPDATE 2-BioMarin Pharma gets DOJ subpoena on sponsored testing programs for two therapies
About
CEO | Mr. Alexander Hardy |
CFO | Mr. Brian R. Mueller CPA |
Address | 770 Lindaro Street, San Rafael, CA, United States, 94901 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 3,401 |
